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The earliest report on probiotics dates back to 1907, when Elie
Metchnikoff described a correlation between the ingestion of lactic
acid–producing bacteria in yogurt and enhanced longevity (Gordon,
2008). During the past few decades, there has been renewed interest in
probiotics not only in regards to digestive health, but also in the manage-
ment of inﬂammatory diseases. The term probiotic has been deﬁned as
“living microorganisms which, when consumed in adequate amounts,
confer a health effect on the host” (World Health Organization and Food
and Agriculture Organization of the United Nations, 2001). Lactobacillus
and Biﬁdobacterium have emerged as two of the most commonly used
probiotics (Ouwehandet al., 2002), althoughnewer strains suchasBacillus
coagulans are being investigatedwithpositive results (Bensonet al., 2012).
Most commonly formulated as fermentation products, probiotics
counter pathogenic bacteria, support barrier function, and contribute
to the regulation of the innate and adaptive immune responses
(Hacini-Rachinel et al., 2009). Probiotics can nowbe found in household
items ranging from yogurt to children’s popsicles to facial cream.
In this review, we discuss the role of probiotics in the development
of the immune system, the treatment of acne, and protection against
aging and photodamage.
Immune regulation
The concept of nature versus nurture is longstanding; however, we
now understand how the environment, speciﬁcally the microbialr, Bayer; consultant and advisory
board, Johnson & Johnson Con-
ultant, Onset Therapeutics; con-
n behalf ofWomen's Dermatologic Soenvironment, can inﬂuence the expression of our genes. While an indi-
vidual may have a genetic predisposition to developing a condition,
such as lupus or diabetes, an exposure to a speciﬁc environmental factor
exerts pressure on the genome, determining if the disease ultimately
develops and/or the disease severity.
Emerging insights into the interactions between probiotics and host
receptors have demonstrated the ability of probiotics to modulate gene
expression and cellular differentiation of the immune system. Given
that the gastrointestinal tract houses the largest reservoir of commensal
bacteria and acts as the body’s largest immune organ, a signiﬁcant body
of research evaluates the inﬂuence of probiotics on the modiﬁcation of
the immune system in the gastrointestinal tract (Benyacoub et al.,
2014; Savage, 1977). The communication among epithelium, macro-
phages, dendritic cells, and micro-organisms in the gastrointestinal
tract results in T-cell differentiation (Sansonetti and Medzhitov, 2009),
ultimately training the innate and adaptive immune systems to achieve
immune homeostasis and tolerance for commensal microbiota (Bron
et al., 2012). The immune system recognizes both pathogenic and com-
mensal bacteria through the family of Toll-like receptors (TLR) (Hemmi
et al., 2000). Proteins located on the surface of bacteria, including lipo-
polysaccharide (LPS), ﬂagellin, and lipoproteins, as well as bacterial
DNA within the cell interact with the TLRs, modifying the immune re-
sponse (Benson et al., 2012). A study using germ-freemice demonstrat-
ed that speciﬁc strains of gut microbiota regulated the expression of
genes involved with nutrient absorption, energy metabolism, intestinal
barrier function, and immunity (Hemarajata and Versalovic, 2013).
Similarly, in humans subjected to probiotic bacteria (Lactobacillus spe-
cies), gene transcription proﬁles of immunity and intestinal barrier var-
ied pre- and post-treatment with probiotics (Van Baarlen et al., 2010).
Although probiotics may exert their effect locally when applied or
ingested, with their inﬂuence on immune regulation, their effects often
extend to other organ systems. Evidence suggests that chronic inﬂamma-
tion and gut microbiota imbalance contributes to obesity, diabetes, can-
cer, depression, and inﬂammatory bowel disease (Hormannsperger and
Haller, 2010; Karin et al., 2006; Kushner et al., 2006; Musso et al., 2011;ciety. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
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the concept of chronic inﬂammation without a clear pathogenic threat.
Short bursts of inﬂammation are required in certain circumstances—for
instance, when a host encounters pathogens such as Staphylococcus
aureusorHerpes SimplexVirus.However, chronic low levels of inﬂamma-
tionwhenno true threat is present contribute tomany so-called “diseases
of Western society,” including but not limited to those listed above. An
ideal probiotic would be capable of boosting the host’s immune response
to true threats, while inhibiting an ongoing immune reaction when no
threat is present. We call this concept “immune regulation.”
Oral probiotics have been shown to improve insulin sensitivity in
animal models (Hsieh et al., 2013) as well as regulate the release of
inﬂammatory cytokines in the skin through their interaction with
gut-associated lymphoid tissue (Hacini-Rachinel et al., 2009). The
gut-brain-skin axis suggests a mechanism that links gastrointestinal
health, inﬂuenced by interactions with oral probiotics, to the health
and well-being of the skin (Bowe and Logan, 2011). Several strains of
Lactobacillus have been shown to have systemic anti-inﬂammatory
effects. Studies have shown that Lactobacillus reuteri 100–23 induces
systemic anti-inﬂammatory cytokines, such as interleukin (IL)-10
(Livingston et al., 2009). Soluble factors from L. reuteri inhibit production
of pro-inﬂammatory cytokines and culture supernatants of murine-
derived L. reuteri 6798 inhibit tumor necrosis factor (TNF) production
of activated macrophages (Livingston et al., 2009; Thomas et al., 2012;
Van Baarlen et al., 2010).
Several strains of Lactobacillus also demonstrate anti-inﬂammatory
properties. The addition of Lactobacillus paracasei NCC2461 has been
shown to inhibit neutrogenic inﬂammation in a skin model, and the ad-
dition of L. paracaseiNCC2461 to lymphocyte culture has been shown to
strongly inhibit the proliferative activity of CD-4+ T-cells in a dose-
dependent manner and to induce the anti-inﬂammatory cytokines IL-
10 and TGF-beta (7). Mice who consumed the probiotic for 7 days
demonstrated a signiﬁcantly higher antibody response and in vivo T-
cell-mediated immune response, indicating L. paracasei affects both B-
and T-cell function (Benyacoub et al., 2014). Similarly, mice treated
with Lactobacillus casei had an increased ability to produce IL-10 and
promote T-regulatory cell function (Hacini-Rachinel et al., 2009). An in-
crease in T-regulatory cells suggests that this probiotic may help to bal-
ance the immune system’s response to stimuli (Hacini-Rachinel et al.,
2009; Pellaton et al., 2012). Consequently, certain probiotic strains
may potentially boost appropriate immune responses, for example to
a harmful pathogenic threat, while dampening the unnecessary im-
mune responses seen in chronic inﬂammatory states.
Similar to Lactobacillus, B. coagulans has been shown to display im-
munoregulatory effects that could potentially impact the health of the
skin. The incubation of peripheral blood mononuclear cells (PBMCs)
and polymorphonuclear (PMN) cells with the supernatant and cell wall
fragments of B. coagulans promoted mature phenotypes of antigen-
presenting cells and inhibited spontaneous and stress-induced reactive
oxygen species (ROS) formation (Benson et al., 2012; Jensen et al.,
2010). We are well aware that ROS and oxidative stress play a role in
acne, making this an intriguing ﬁnding with potential beneﬁt for the
acne patient (Bowe and Logan, 2010).
Disruption of skin barrier function is a known side effect of many
acne medications including topical retinoids and benzoyl peroxide.
The irritation, stinging, and dryness resulting from these medications
can negatively impact compliance with an acne regimen. Rosacea and
atopic dermatitis are other skin conditions in which the skin barrier is
impaired, and symptoms improve when the skin barrier is strength-
ened. Oral ingestion of certain probiotic strains has been shown to im-
prove the skin barrier and affect skin hydration and transepidermal
water loss. Gueniche et al. (2014) studied the effects of oral supplemen-
tation with L. paracasei NCC2461 versus placebo for healthy female vol-
unteers via a randomized placebo-controlled clinical trial. A capsaicin
test was used to monitor skin sensitivity, while transepidermal water
loss and dermatological assessments were utilized to measure skinbarrier function. Both skin sensitivity and skin barrier function improved
in the probiotic group. The probiotic group also showed increases in the
serum concentration of TGF-beta after 29 days compared to no increase
in the placebo group. TGF-beta has been shown to play a signiﬁcant role
in skin integrity (Hashimoto, 2000; Pasonen-Seppanen et al., 2003).
Overall, probiotics modulate the development of the immune sys-
tem, often shifting the immune response toward regulatory and anti-
inﬂammatory conditions. This ability of probiotics tomodify chronic in-
ﬂammatory states suggests that probiotics may have a role in treating
chronic inﬂammatory conditions, ranging from inﬂammatory bowel
disease to reactive airway disease to acne, rosacea, atopic dermatitis,
and photoaging (Benyacoub et al., 2014; Bowe, 2013).Acne
Through basic science and animal and human clinical trials, the evi-
dence is growing for the use of probiotics in the treatment of acne. Acne
formation is dependent upon several processes, including follicular
hyperkeratinization, excess sebum production, Propiobacterium acnes
colonization, and an inﬂammatory cascade (Baquerizo Nole et al.,
2014). Successful acne outcomes are inﬂuenced by compliance with
topical regimens that can commonly cause skin barrier disruption, lead-
ing to dryness and irritation. Consequently, calming inﬂammation as
well asmaintaining skin hydration and barrier repair are of primary im-
portance when treating acne. Probiotics modify several factors in the
pathophysiology of acne development and can potentially improve
compliance as well.
At the basic science level, probiotics have been shown to directly in-
hibit P. acnes through the production of antibacterial proteins. In vitro
Streptococcus salivarius, a prominent component of the oropharynx,
has been shown to inhibit the growth of P. acnes and group A strepto-
cocci through the production of a bacteriocin-like inhibitory substance
(BLIS-like substance) (Bowe et al., 2006). Similarly, strains of
Lactococcus sp. HY 449 exhibit antimicrobial activity and inhibit the
growth of Staphylococcus epidermidis, Staphylococcus aureus, Streptococ-
cus pyogenes, and P. acnes through the secretion of bacteriocins (Oh
et al., 2006). Clinically, the topical application of probiotics has also
been shown to modify the barrier function of the skin with a secondary
increase in antimicrobial properties of the skin. Speciﬁcally, Streptococ-
cus thermophiles, applied as a cream for 7 days, has been shown to in-
crease ceramide production both in vitro and in vivo (Di Marzio et al.,
1999, 2003, 2008). Not only do ceramides trap moisture in the skin,
but certain ceramide sphingolipids, such as phytosphingosine (PS), ex-
hibit direct antimicrobial activity against P. acnes. The clinical applica-
tion of PS has been further substantiated by a 2-month pilot study
showing an 89% reduction of acneiform papules and pustules after the
application of 0.2% PS (Pavicic et al., 2007). By decreasing the counts
of P. acnes on the surface of the skin, probiotics target one factor contrib-
uting to acne formation. By inducing the production of healthy
ceramides, it helps restore healthy fats, which can beneﬁt acne directly
and counter common side effects resulting from acne therapies.
The immunomodulatory effects of probiotics on keratinocytes and
epithelial cells suggest a physiologic mechanism to support the use of
probiotics as an adjuvant treatment of acne. Strain K12 of S. salivarius
inhibited production of the pro-inﬂammatory cytokine IL-8 in epithelial
cells and keratinocytes, likely through the inhibition of the NK-kappaB
pathway (Cosseau et al., 2008). This inhibition ofmultiple inﬂammatory
pathways suggests that S. salivarius acts as an immunemodulator when
applied directly to the epithelium (Cosseau et al., 2008). Cultures of
human skin treated with L. paracasei NCC2461 showed inhibition of
substance-P–induced skin inﬂammation, as measured by reduction of
vasodilation, edema, mast cell degranulation, and tumor necrosis factor
alpha (TNF-alpha) release (Gueniche, Bastien et al., 2010; Gueniche,
Benyacoub et al., 2010). As substance-P may amplify inﬂammation
and sebum production, its inhibition lends itself toward therapeutic
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ﬂammatory cascade again targets a factor in the pathogenesis of acne.
Two clinical trials of topical preparations of probiotics have assessed
their effect on acne. The ﬁrst trial applied Enterococcus fecalis lotion to
the face for 8 weeks; a 50% reduction of inﬂammatory lesions was
noted compared to placebo (Kang et al., 2009). A reduction in acne
count, size, and associated erythema was again noted during a clinical
study of Lactobacillus plantarum 5% extract, although these ﬁndings
were not supported with the 1% extract (Muizzuddin et al., 2012), sug-
gesting the effects may be dose dependent.
Revisiting the gut–brain–skin axis, oral probiotics exert their effect
on the skin through various potential mechanisms, including reduction
of systemic inﬂammation and inﬂuence on absorption (Bowe et al.,
2014). Oral administration of L. reuteri in stressed animals demonstrat-
ed signiﬁcantly lower rates of perifollicular inﬂammation than controls,
and the administration of oral probiotics has been shown to limit the
major histocompatibility cell (MHC) class II surrounding hair follicles
(Arck et al., 2010). Given that perifollicular inﬂammation appears to
be one of the ﬁrst steps in the acne process, impacting this early inﬂam-
mation might have a preventative beneﬁt in acne.
Insulin-like growth factor 1 (IGF-1) has also been shown to play a
role in the pathogenesis of acne. This suggests that certain foods or pro-
biotic strainsmay play a role in acne through their modulation of IGF-1.
Low-ﬁber carbohydrates and dairy have been associated with an in-
creased risk in acne development, likely driven by an increase in (IFG-
1) (Adebamowo et al., 2006, 2008; Bowe et al., 2010). Supplementation
of the probiotic Lactobacillus to the fermentation process of milk dem-
onstrated a four-fold lower level of IGF-1 comparedwith nonfermented
skim milk (Quadros et al., 1994). These ﬁndings suggest that probiotics
may decrease systemic levels of IGF-1, improving acne from a systemic
and mechanistic level.
The physician Robert H. Siver conducted the ﬁrst clinical trial evalu-
ating the effects of probiotics on acne in the 1960s. He studied the ef-
fects of an oral, commercially available probiotic (Lactinex composed
of L. acidophilus and L. bulgaricus) in 300 patients (Bowe et al., 2014). Al-
though the regimen he prescribed was unconventional, consisting of
oral probiotics for 8 days followed by a 2-week break, then repeated,
he observed that 80% of patients had some improvement, primarily in
the inﬂammatory lesions (Bowe et al., 2014). However, a major limita-
tion to his study was a lack of placebo controls. Despite this major lim-
itation, he concluded that there might be an interaction between gut
metabolic processes and manifestations on the skin (Siver, 1961).
More recent studies evaluating the role of oral probiotics on acne
have largely been published in foreign journals. In an Italian study of
40 patients, one half received an oral supplement consisting of 250 mg
of freeze-dried L. acidophilus and Biﬁdobacterium biﬁdum as an adjuvant
to standard treatment (Marchetti et al., 1987). The group receiving the
probiotic experienced improved clinical outcome and resolution of
acneiform lesions compared to the nonsupplemented group, as well as
demonstrated better tolerance for oral antibiotics (Marchetti et al.,
1987). Similarly, a study out of Russia evaluated acne patients for
impaired bacterial microﬂora, and patients received intestinal “micro-
ﬂora correcting agents” in addition to traditional acne therapy
(Volkova et al., 2001). A more rapid clinical improvement was noted
in those receiving the supplement (Volkova et al., 2001). Although the
designs of these studies aremore difﬁcult to evaluate, they suggest a po-
tential role for oral probiotics as an adjuvant in acne therapy.
A recent clinical trial demonstrated that oral antibiotics and
probiotics might provide synergistic beneﬁts, speciﬁcally for inﬂamma-
tory acne (Jung et al., 2013). Forty-ﬁve females, aged 18 to 35 years,
were randomly assigned to one of three arms: probiotic supplementa-
tion only, minocycline only, or both probiotics and minocycline. All pa-
tients showed a signiﬁcant improvement in total lesion count at 4
weeks, with continued improvement throughout the 12-week study.
However, the group taking both probiotics and minocycline had a sig-
niﬁcant decrease in total lesion count as compared to the other twogroups. Furthermore, two patients from theminocycline-only group de-
veloped vaginal candidiasis. One randomized-controlled trial from
Korea assigned acne patients to either receive fermented milk only or
fermented milk with 200 mg of lactoferrin daily for 12 weeks (Kim
et al., 2010). Lactoferrin, a glycoprotein, is a component of the innate
immune systemwith bactericidal and fungicidal properties. The total le-
sion count and grade, aswell as sebum content, were assessedmonthly.
The group receiving the lactoferrin-enriched fermented milk showed a
greater decrease in total lesion count compared to fermented milk
alone (56% versus 32.2%), largely through the decrease in triacylglycer-
ols in skin surface lipids (Kim et al., 2010). Although the additional
lactoferrin to the oral probiotic beverage demonstrated a greater de-
crease than the probiotic alone, the substantial decrease noted by the
administration of an oral probiotic alone further supports the role of
probiotics as an adjuvant in acne treatment.
Aging skin and protection from ultraviolet light
Aging skin involves a complex interplay between intrinsic aging, in-
cluding genetic and hormonal inﬂuences, and extrinsic aging, which is
subject to environmental factors such as ultraviolet (UV) light, trauma,
pollution, infections, and cigarette smoking. At the molecular level, al-
terations in aging skin include an increase in skin pH, a decreased ability
to quench reactive oxygen species, and increased matrix metallopro-
teinase activity (Cinque et al., 2010). UV radiation is considered the
strongest precipitator of extrinsic aging. As public knowledge has in-
creased regarding the link between sun exposure and photoaging, inter-
est in preventing and treating the adverse effects of UV radiation has
escalated. Early studies suggest that probiotics and their metabolites
might alter several aspects of skin aging.
Healthy, normal skin exhibits a slightly acidic pH in the range of 4.2-
5.6, which aids in the prevention of pathogenic bacterial colonization,
regulation of enzyme activity, andmaintenance of amoisture-rich envi-
ronment (Mauro, 2006); however, after the age of 70, the pH of skin
rises signiﬁcantly, stimulating protease activity (Hachem et al., 2003).
Probiotic metabolism frequently produces acidic molecules, lowering
the pH of the surrounding environment (Cinque et al., 2010), as seen
with Lactobacilli producing free fatty acids (FFAs) and conjugated
linoleic acid (CLA) during the fermentation process (Yadav et al.,
2007). Theoretically, therefore, the use of probiotics may work to re-
store the normal skin pH and consequently return protease activity
levels closer to those seen in young, healthy skin.
Free radicals form as a result of normal metabolic processes, but
their production increases in the face of certain environmental factors,
including UV light, pollution, and cigarette smoke. As we age and expe-
rience multiple such assaults in our environment, our own antioxidant
defense system can become overwhelmed, allowing free radicals and
ROS to damage cellular structures including DNA, lipids, and proteins
such as collagen (Cinque et al., 2010). In vitro B. coagulans RK-02 pro-
duces extracellular polysaccharides, high-molecular-weight polymers
composed of fourmonosaccharides. These extracellular polysaccharides
have demonstrated signiﬁcant antioxidant and free radical scavenging
properties (Kishk and Al-Sayed, 2007; Kodali and Sen, 2008). Interest-
ingly, by providing a heterologous superoxide dismutase to Lactobacilli
that do not ordinarily produce this antioxidant enzyme, researchers
were able to demonstrate that these Lactobacilli could produce superox-
ide dismutase and offer protection against peroxide free radicals
(Bruno-Barcena et al., 2004). These studies suggest probiotics in their
natural state, or after genetic modiﬁcation, may slow aging of the skin
by helping to restore the balance between free radical scavengers and
the free radical production.
Probiotics have been shown to inﬂuence and alter the immune sys-
tem. The question then arises whether probiotics may exert their inﬂu-
ence on cutaneous homeostasis and regulation of the immune system in
the setting of UV light exposure. Ultraviolet radiation (UVR) has long
been known as a major contributor to aging skin, a term now widely
Table 1
Probiotics and Ultraviolet Light.
Study Probiotic strain Model Findings
Kim et al., 2014 Lactobacillus
plantarum HY7714
Human dermal ﬁbroblasts
and hairless mice
L. plantarum inhibited UVB-induced matrix metalloproteinase 1 (MMP-1)
expression to preserve procollagen expression in human ﬁbroblasts. Oral
administration of L. plantarum reduced the number and depth of wrinkles
in hairless mice compared to control. Histologic samples from the hairless
mice demonstrated that L. plantarum inhibited MMP-13, MMP-2, and
MMP-9 expression in dermal tissue.
Weill et al., 2013 Lactobacillus
rhamnosus GG
Female hairless mice Hairless mice administered L. rhamnosus produced higher levels of interferon-
gamma in lymph nodes and numbers of total, helper, and cytotoxic T-cells
compared to controls. A delay in ultraviolet radiation–induced tumors was
noted in mice receiving L. rhamnosus.
An increase in IgA antibodies in the small intestine was noted.
Sugimoto et al., 2012 Biﬁdobacterium breve
strain Yakult (BBY)
Hairless mice BBY suspensions and fermented milk containing BBY administered for 9 and
14 days, respectively, suppressed the production of UV-induced elastase and
IL-1beta and prevented a loss of elasticity associated with ultraviolet light
exposure.
Peguet-Navarro et al., 2008 Lactobacillus
johnsonii (La1)
Randomized, double-blind
controlled trial of 54
healthy volunteers
Oral administration of La1 demonstrated restoration of CD1a Langerhans cell
markers compared to placebo at day 4 post-ultraviolet radiation (UVR). No
difference in immunostains was noted 1-day post UVR.
Gueniche et al., 2009 Lactobacillus johnsonii
NCC 533 (La1)
Randomized, double-blind
controlled trial of 54
healthy volunteers
Oral administration of La1 for 8 weeks did not prevent early UV-induced
activation of Langerhans cells after exposure to 2 × 1.5 MED UV radiation.
However, La1 increased recovery of allostimulatory function compared
to placebo.
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creased skin fragility, and the presence of solar lentigos. Acute effects
of UVR result from the direct effect of UVR on DNA and the modulation
of the immune system through the release of inﬂammatory cytokines
and, ultimately, immunosuppression (Kock et al., 1990; Schwarz and
Schwarz, 2002).
Probiotics are emerging as a therapy to mitigate or prevent the ef-
fects of UV-induced skin damage. In hairless mice, the oral administra-
tion of Biﬁdobacterium breve prevented UV-induced transepidermal
water loss compared to mice receiving placebo. Additionally, the
administration of B. breve suppressed the UV-induced increase in hy-
drogen peroxide levels, oxidation of proteins, and xanthine oxidase ac-
tivity in the skin (Ishii et al., 2014). These ﬁndings suggest that oral
administration of probiotics may at least partially alleviate UV-
induced barrier changes and oxidative stress in the skin.
Human studies have substantiated the role of oral probiotics in atten-
uating UV-induced photodamage. The probiotic Lactobacillus johnsonii
and 7.2 mg of carotenoids were administered to healthy women for 10
weeks, then subjects were exposed to either simulated or natural sun-
light. Compared to placebo, dietary supplementation prevented the
UV-induced decrease in Langerhans cell density and accelerated the re-
covery of immune system homeostasis after exposure to UVR (Bouilly-
Gauthier et al., 2010). Comparison of the minimal erythema dose
(MED) showed that in those receiving supplementation, the MED rose
by 20% (Bouilly-Gauthier et al., 2010). These results suggest that oral pro-
biotic supplementation might play a role in mitigating the detrimental
effects of UV exposure; however, without control groups to delineate
the effects of probiotics versus carotenoids independently, it is difﬁcult
to attribute the ﬁndings to one compound in the dietary supplement.
This represents a signiﬁcant limitation to the study.
Refer to Table 1 for the complete list of probiotics and photoprotection.
Future Directions
While the evidence supporting the use of probiotics for acne and
anti-aging is clearly mounting, several questions remain. First, which
will ultimately beneﬁt the skin to a greater extent: oral ingestion or top-
ical application? Alternatively, will a combination approach of oral and
topical prove to be the most effective? Will live probiotic strains offer
an advantage to using probiotic derivatives, metabolites, or superna-
tants? Will live strains be capable of surviving on the skin, and if so,
for how long? What is the minimal dose or concentration necessary ofeach probiotic required to see a beneﬁt, and is a mixture of probiotics
synergistic as compared to use of one particular strain?
As our understanding of the human microbiome grows, we deepen
our appreciation of how individualized and complex each person’s
microbial environment is. We envision a need to ultimately custom tai-
lor an oral and skin care regimen to each and every patient after sam-
pling that patient’s unique microbial “ﬁngerprint.” A one-size-ﬁts-all
approach is very unlikely to achieve optimal resultswhen it comes to al-
tering an individual’smicrobiome. Althoughwe are only now skimming
the surface of this exciting ﬁeld, early studies suggest that oral and top-
ical probiotics hold potential in the treatment of acne as well as in
photoprotection and slowing the signs of aging skin.References
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